Evolving market pressures are changing the focus of the drug development industry, further accelerating early phases in order to create late-stage pipeline growth.

Our IND eGuide will help you understand how and when to plan your preclinical IND-enabling program as an integral part of meeting specific milestones necessary to timely and efficient IND submission.


Download the IND eGuide PDF